Pharma groups redouble patient-centric efforts

Pharma groups redouble patient-centric efforts

Driven by 2020’s highlights, international pharma giants are planning to deliver more vital medicines and vaccines to Vietnam in 2021 to tap into local demands and enable the country to weather future crises.
Promising figures offering confidence for pharma future

Promising figures offering confidence for pharma future

Vietnamese pharmaceutical giants rushed to new business lines in 2020 to create new motivation for growth amid the ongoing pandemic complications, with some changes bringing about better results.
Recall of drug spoils pharma reputation

Recall of drug spoils pharma reputation

Public concerns have ignited over the recall of a popular anti-allergy drug produced by BRV Healthcare, a joint venture between domestic group BV Pharma and UK firm RV Group.
Fresh rules to tackle pharma misconduct

Fresh rules to tackle pharma misconduct

Violations in the pharmaceutical industry are seemingly never-ending, with Young Il Pharm, USV Private, and Armepharco being among recent prominent names. However, future wrongdoings may be better resisted when new stricter rules come into effect next month.
Pharma violators in tender fiasco

Pharma violators in tender fiasco

A number of big pharma companies have been caught violating drug tenders to turn a profit, triggering public concerns over their code of ethics.
Vaccine sales stir big pharma

Vaccine sales stir big pharma

Amidst lower-than-expected business performance, international pharma giants are betting on COVID-19 vaccine sales, hoping to alter the headwinds from the health crisis to their advantage.
Pharma firms uphold fair price mechanisms

Pharma firms uphold fair price mechanisms

Amid Vietnam’s upcoming new rules on drug tenders, multinational pharma giants are advocating price negotiation for an open business environment and predictable policies, in order to make sustainable future investments.
Pharma firms aiming for GMP certificates

Pharma firms aiming for GMP certificates

Despite strict requirements, international pharma giants like Novartis, AstraZeneca, and Pfizer are rushing to complete all necessary procedures to receive the most sought-after GMP recognition for their manufacturing sites, signalling a hotter tender market in the months to come.
Big pharma preparing for new phase under EVFTA

Big pharma preparing for new phase under EVFTA

The Ministry of Health has made advancements in regulations to facilitate multinational pharmaceutical corporations and to make them align with the EU-Vietnam Free Trade Agreement.
Replaced regulation to hit global drugmakers

Replaced regulation to hit global drugmakers

International pharma giants like Pfizer, GSK, and Novartis are expected to be strongly hit soon by a price cut under Vietnam’s new tender rules for branded drugs, enabling local patients to receive an increase in pharmaceutical access at affordable prices.
Ups and downs in pharma industry due to crucial supply chain hiccups

Ups and downs in pharma industry due to crucial supply chain hiccups

After months of challenges and faults in the global ingredient supply chain, peaks and valleys are the landscape for Vietnamese drug giants in their first-half performance, and several factors remain that could damage their operational prospects in the months to come.
SK Group expands pharma foothold

SK Group expands pharma foothold

With SK Group recently joining the mergers and acquisitions race, Vietnam’s pharma and healthcare market is becoming more robust. However, newcomers are expected to face challenges amid increasingly mounting competition in the lucrative pharmaceutical market in the months to come, driven by the enforcement of the EU-Vietnam Free Trade Agreement.
Global pharma groups push on with operations

Global pharma groups push on with operations

Despite having risk management solutions to ensure drug import continuity to Vietnam in response to EU border closures, international pharma giants Sanofi, Zuellig Pharma, Adamed, and Novartis are closely monitoring the situation due to the potential direct impacts on long-term supply security.    
Pharma landscape set for shake-up

Pharma landscape set for shake-up

Facing significant expansion from multinational corporations, Vietnamese drug giants took a hit in 2019 despite new strategies, signalling an uninspiring outlook for future growth.  
Pharma initiatives  to cure the needy

Pharma initiatives to cure the needy

Multinational pharmaceutical groups are seeking ways to support Vietnamese in accessing medical services, and widen their market share in the country in the face of drastic competition.
|< < 1 2 3 4 > >|